ECO Animal Health Group PLC
LSE:EAH
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
ECO Animal Health Group PLC
Total Current Liabilities
ECO Animal Health Group PLC
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
E
|
ECO Animal Health Group PLC
LSE:EAH
|
Total Current Liabilities
£16.4m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
5%
|
|
|
GlaxoSmithKline PLC
LSE:GSK
|
Total Current Liabilities
£21.4B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
AstraZeneca PLC
LSE:AZN
|
Total Current Liabilities
$30.6B
|
CAGR 3-Years
5%
|
CAGR 5-Years
9%
|
CAGR 10-Years
7%
|
|
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
Total Current Liabilities
$1.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Allergy Therapeutics PLC
LSE:AGY
|
Total Current Liabilities
£27.2m
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
14%
|
|
|
A
|
Alliance Pharma PLC
LSE:APH
|
Total Current Liabilities
£36.7m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
9%
|
CAGR 10-Years
12%
|
|
ECO Animal Health Group PLC
Glance View
ECO Animal Health Group Plc engages in the development, registration and marketing of pharmaceutical products for animals. The company is headquartered in New Malden, Surrey and currently employs 207 full-time employees. The firm's segments include UK, China and Japan, North America, South and South East Asia, Latin America, Europe and the Rest of the World. The firm's principal activity is the manufacture and supply of animal health products across the globe. These activities are conducted on a global scale, through a network, including both regional offices (notably in Shanghai and Princeton) and overseas subsidiaries. Its products include Aivlosin, Ecomectin and others. Aivlosin is a macrolide antibiotic for treatment of respiratory and enteric diseases in pigs and poultry. Ecomectin is an endectocide that controls worms, ticks, lice and mange in grazing stock and pigs. Its Ecoheart, Ecotraz and Ecomintic are for the treatment and prevention of parasites in cattle, sheep, pigs, horses and dogs.
See Also
What is ECO Animal Health Group PLC's Total Current Liabilities?
Total Current Liabilities
16.4m
GBP
Based on the financial report for Sep 30, 2025, ECO Animal Health Group PLC's Total Current Liabilities amounts to 16.4m GBP.
What is ECO Animal Health Group PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 10Y
5%
Over the last year, the Total Current Liabilities growth was -3%. The average annual Total Current Liabilities growth rates for ECO Animal Health Group PLC have been -4% over the past three years , and 5% over the past ten years .
